Recursion Pharmaceuticals, Inc. (RXRX)
3.975
-0.38
(-8.83%)
USD |
NASDAQ |
Oct 12, 13:55
Recursion Pharmaceuticals Free Cash Flow (Quarterly) : -107.91M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -107.91M |
| March 31, 2026 | -81.44M |
| December 31, 2025 | -47.32M |
| September 30, 2025 | -117.60M |
| June 30, 2025 | -81.73M |
| March 31, 2025 | -133.79M |
| December 31, 2024 | -117.08M |
| September 30, 2024 | -63.79M |
| June 30, 2024 | -86.40M |
| March 31, 2024 | -108.95M |
| December 31, 2023 | -76.49M |
| September 30, 2023 | -73.75M |
| June 30, 2023 | -71.44M |
| Date | Value |
|---|---|
| March 31, 2023 | -78.66M |
| December 31, 2022 | -52.73M |
| September 30, 2022 | -63.10M |
| June 30, 2022 | -78.10M |
| March 31, 2022 | 73.05M |
| December 31, 2021 | -65.62M |
| September 30, 2021 | -42.75M |
| June 30, 2021 | -39.86M |
| March 31, 2021 | -50.17M |
| December 31, 2020 | 3.982M |
| September 30, 2020 | -20.28M |
| June 30, 2020 | -17.33M |
| March 31, 2020 | -18.50M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Absci Corp. | -27.56M |
| Twist Bioscience Corp. | -8.648M |
| Editas Medicine, Inc. | -29.67M |
| Amgen, Inc. | 3.489B |
| Halozyme Therapeutics, Inc. | 236.72M |